Literature DB >> 24940471

Sildenafil can induce the onset of a cluster headache bout.

Guan-Yu Lin1, Jiunn-Tay Lee1, Giia-Sheun Peng1, Fu-Chi Yang1.   

Abstract

About 25% of patients who are prescribed sildenafil, the phosphodiesterase type 5 (PDE-5) inhibitor, for erectile dysfunction (ED) experience headaches. These migraine effects are well-described, including cluster headaches. We report the case of a man who experienced a cluster headache attack following each of 2 sildenafil doses. His symptoms were resolved by adding naproxen to his treatment regimen and changing his ED treatment from 50 mg of sildenafil to 5 mg of vardenafil. To our knowledge, no study has reported cluster headaches triggered by the less commonly used PDE-5 inhibitors, namely vardenafil and tadalafil. Urologists should be cautious in prescribing sildenafil to patients with ED and with a history of cluster headaches. In these patients, they should consider prescribing low-dose vardenafil or tadalafil instead. Failure to recognize sildenafil risks could result in unnecessary headache bouts in patients with a history of cluster headaches.

Entities:  

Year:  2014        PMID: 24940471      PMCID: PMC4039608          DOI: 10.5489/cuaj.1736

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  13 in total

Review 1.  Current status of local penile therapy.

Authors:  F Montorsi; A Salonia; M Zanoni; P Pompa; A Cestari; G Guazzoni; L Barbieri; P Rigatti
Journal:  Int J Impot Res       Date:  2002-02       Impact factor: 2.896

2.  Guidelines on erectile dysfunction.

Authors:  Eric Wespes; Edouard Amar; Dimitrios Hatzichristou; Francesco Montorsi; John Pryor; Yoram Vardi
Journal:  Eur Urol       Date:  2002-01       Impact factor: 20.096

3.  Cluster headache attack due to sildenafil intake.

Authors:  M de L Figuerola; O Bruera; J Lestón; J Ferreiro
Journal:  Cephalalgia       Date:  2006-05       Impact factor: 6.292

4.  Viagra and cluster headache.

Authors:  M Stein
Journal:  Headache       Date:  1999-01       Impact factor: 5.887

5.  Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'.

Authors:  M Braun; G Wassmer; T Klotz; B Reifenrath; M Mathers; U Engelmann
Journal:  Int J Impot Res       Date:  2000-12       Impact factor: 2.896

Review 6.  Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil--review of the literature.

Authors:  Ursula Gresser; C H Gleiter
Journal:  Eur J Med Res       Date:  2002-10-29       Impact factor: 2.175

7.  Side-effect profile of sildenafil citrate (Viagra) in clinical practice.

Authors:  S G Moreira; R E Brannigan; A Spitz; F J Orejuela; L I Lipshultz; E D Kim
Journal:  Urology       Date:  2000-09-01       Impact factor: 2.649

Review 8.  Pathophysiology of trigeminal autonomic cephalalgias.

Authors:  Massimo Leone; Gennaro Bussone
Journal:  Lancet Neurol       Date:  2009-08       Impact factor: 44.182

Review 9.  Spotlight on vardenafil in erectile dysfunction.

Authors:  Gillian M Keating; Lesley J Scott
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 10.  Cluster headache.

Authors:  Jacqueline Weaver-Agostoni
Journal:  Am Fam Physician       Date:  2013-07-15       Impact factor: 3.292

View more
  1 in total

1.  Cerebrovascular Reactivity Measures Are Associated With Post-traumatic Headache Severity in Chronic TBI; A Retrospective Analysis.

Authors:  Franck Amyot; Cillian E Lynch; John Ollinger; J Kent Werner; E Silverman; Carol Moore; Cora Davis; L Christine Turtzo; Ramon Diaz-Arrastia; Kimbra Kenney
Journal:  Front Physiol       Date:  2021-05-13       Impact factor: 4.566

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.